Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays
about
Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomasComplexity of receptor tyrosine kinase signal processing.Axl as a mediator of cellular growth and survivalRedundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors.ZEPHYR illustrates the perils of testing targeted treatments in unselected non-small-cell lung cancer patients.Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches.miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer.Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA)Reverse phase protein arrays: mapping the path towards personalized medicine.Glucose starvation induces mutation and lineage-dependent adaptive responses in a large collection of cancer cell lines.Global Conservation of Protein Status between Cell Lines and XenograftsImplications of functional proteomics in breast cancer.Molecular insights of Gas6/TAM in cancer development and therapy.Proteomic analysis of tissue samples in translational breast cancer research.Protein arrays for biomarker discovery in lupus.Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.Cell signaling regulation by protein phosphorylation: a multivariate, heterogeneous, and context-dependent process.Systematic analysis of BRAF(V600E) melanomas reveals a role for JNK/c-Jun pathway in adaptive resistance to drug-induced apoptosis.Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer.Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies.Signaling pathway profiling using reverse-phase protein array and its clinical applications.Harnessing Integrative Omics to Facilitate Molecular Imaging of the Human Epidermal Growth Factor Receptor Family for Precision Medicine.Reverse Phase Protein Arrays for Compound Profiling.Combined treatment with MET inhibitors and other therapies in lung cancer.Quantitative analysis of signaling networks across differentially embedded tumors highlights interpatient heterogeneity in human glioblastoma.Protein Arrays III: Reverse-Phase Protein Arrays.Identification of cellular responses to low-dose radiation by the profiling of phosphorylated proteins in human B-lymphoblast IM-9 cells.The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer.Current applications of antibody microarrays.Genetic disruption of calpain-1 and calpain-2 attenuates tumorigenesis in mouse models of HER2+ breast cancer and sensitizes cancer cells to doxorubicin and lapatinib
P2860
Q34062012-8906260D-CC5B-49ED-A7E2-ABCB1633120BQ34361161-28F5222A-1433-4BC0-8CB7-19A2EE83CAB4Q34619118-A6486CF6-56FE-4F14-B63C-A25E38C34DFEQ34704781-CEFA630A-8199-441B-BF16-2FE5C0994587Q35200483-25C77B18-D06C-496F-8DC7-B3E2E36C1F86Q35675442-7D41D558-2030-4821-B574-01312560C159Q35897588-1BDD0D7E-C130-419C-A107-D42E87199B18Q36111215-141629E0-D829-43A2-94D7-960E9B6B7622Q36134032-7A41B44F-3A88-48C2-8332-28D3C475768BQ36519831-ECE3D6EC-789B-49DB-84DD-9D2425470B41Q36525420-0C48C392-D641-4F70-BB47-36FE15E48BCDQ37221907-072AA265-D61C-455F-8D7C-52B66E55BE07Q37698227-EF9D1C1E-996B-4FA9-B273-6C50DCDC1BA5Q37745358-19728FF9-7D02-4124-8700-02EAF028DBCDQ38212502-73BA053E-96FF-4974-B4D2-46C8A34EB40AQ38673773-DB44A664-0C76-4717-B80B-8799F2C1E33BQ38835745-AC96601F-2D72-4DC9-A35A-5478F3BCC6BEQ38890784-73203155-0BB9-47AC-8BF8-8F9257621F37Q38894416-6A0A9BDC-8F2C-445C-8CF5-9F4F290FA1D3Q38900933-2C9CD3CE-C609-454B-8167-1C67641E6011Q39157476-96F27FE8-A5AC-4270-BF21-B55EDDAAA21EQ39377837-E0A2780A-38CB-4499-9B14-00FBE0313C57Q39389369-69F52A1C-1A85-4BB0-A6AF-5313F81F51C4Q41688304-2CD434C3-12EA-4D55-8880-F8465F03CB7FQ41881663-4333D1EB-B234-4AFD-9A50-73D327C01293Q42998414-D4138FCB-E16A-4EFB-9916-5EE226B10F48Q47593253-950E0DAB-6EDF-4D23-AE53-F2A31BE474ACQ47842853-4F8C7493-762E-4641-BCAF-ECA604353357Q51146366-D84154E8-D0CB-4278-8F74-A3B0B29FE01DQ55040593-AE16F891-D63D-416D-A1CC-17AF309343CFQ57117017-8EF9411D-D00E-442F-969E-EBC04F4DA816
P2860
Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays
@en
type
label
Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays
@en
prefLabel
Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays
@en
P2093
P2860
P356
P1433
P1476
Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays
@en
P2093
G MacBeath
P E Schwartz
T S Gujral
P2860
P2888
P304
P356
10.1038/ONC.2012.378
P407
P577
2012-09-03T00:00:00Z
P5875
P6179
1029157397